<link rel="stylesheet" href="https://s3.amazonaws.com/aga-lms-assets/styles/master_styles.css">

<div class="row">
    <!-- Left Side Content -->
    <div class="col-md-7">
        <!-- Book -->

        <nav>
            <div class="nav nav-tabs" id="nav-tab" role="tablist">
                <a class="nav-item nav-link active" id="nav-home-tab" data-toggle="tab" href="#nav-home" role="tab"
                    aria-controls="nav-home" aria-selected="true">Description</a>

                <a class="nav-item nav-link" id="nav-credit-tab" data-toggle="tab" href="#nav-credit" role="tab"
                    aria-controls="nav-credit" aria-selected="false">Financial disclosure</a>
            </div>
        </nav>
        <div class="tab-content" id="nav-tabContent">
            <div class="tab-pane fade show active" id="nav-home" role="tabpanel" aria-labelledby="nav-home-tab">
                <!-- Description -->
                <p class="mt-1">The 8th annual Gut Microbiota for Health (GMFH) World Summit was held on March 23 &amp;
                    24, 2019, in Miami, Florida. Organized jointly by AGA and the European Society of
                    Neurogastroenterology and Motility (ESNM), the GMFH World Summit is the preeminent meeting on the
                    gut microbiota. These on-demand recordings provide a "best of" look at the 2019 sessions, which
                    focused on the interaction between diet, nutrition and the gut microbiome.</p>
                <p class="mt-1"><a class="btn btn-dark"
                        style="background-color:#1E385A; color:#fff; border-radius:0; padding:10px; margin-bottom: 10px"
                        href="http://agau.gastro.org/diweb/gateway/init/1/f/catalog*2Fitem*2Feid*2FGMFH-Rec">Sign in to
                        access</a></p>
                <p>After you sign in, please click the "Launch" button on the top of this page to access the quiz.</p>
                <h5 class="mt-1">Product features:</h5>
                <ol>
                    <li>Current Understanding of the Human Microbiome - Jack A. Gilbert, PhD, University of California,
                        San Diego</li>
                    <li>FODMAPs and IBS - Magnus Simrén, MD, PhD, University of Gothenburg (Sweden)</li>
                    <li>Microbiome Dynamics in Metabolic Diseases - Christoph Thaiss, PhD, University of Pennsylvania
                    </li>
                    <li>Low Dietary Fiber-Induced Mucosal Erosion Worsens Spontaneous Colitis in Genetically Susceptible
                        Hosts - Eric Martens, PhD, University of Michigan</li>
                    <li>Dietary Fiber and Foundation Guild of Healthy Gut Microbiota - Liping Zhao, PhD, Rutgers, The
                        State University of New Jersey</li>
                    <li>Exercise, Fitness, Diet and the Gut Microbiome - Paul Cotter, PhD, University College Cork
                        (Ireland)</li>
                    <li>Microbe-Derived Metabolites and the Liver - Rohit Loomba, MD, University of California, San
                        Diego</li>
                </ol>
                <h5 class="mt-1">&nbsp;</h5>
                <h5 class="mt-1">Course directors and faculty:</h5>
                <p class="mt-1">Gail Hecht, MD, MS, AGAF (co-chair)<br>
                    Francisco Guarner, MD, PhD (co-chair)<br>
                    Giovanni Barbara, MD<br>
                    Joël Doré, PhD<br>
                    Dirk Haller, PhD<br>
                    Purna Kashyap, MBBS<br>
                    Colleen Kelly, MD<br>
                    Emeran Mayer, MD<br>
                    D. Brent Polk, MD, AGAF<br>
                    R. Balfour Sartor, MD<br>
                    Robert Schwabe, MD<br>
                    Hania Szajewska, MD<br>
                    Michael Trauner, MD, AGAF<br>
                    Gary D. Wu, MD, AGAF
                    <!-- Learning Objectives -->
                </p>
                <h5 class="title-color">Learning objectives</h5>
                <ul>
                    <li>Understand the role of diet-microbiota interactions underlying human health and disease.</li>
                    <li>Describe current evidence regarding dietary components (such as dietary fiber and fermented
                        foods) and exercise and their influence on the human gut microbiome.</li>
                    <li>Describe current understanding of metabolites produced by the gut microbiome and their link to
                        human health and disease.</li>
                    <li>Apply current understanding of probiotics for the management of adult and pediatric
                        gastrointestinal disorders to clinical practice.</li>
                </ul>

                <h5>Pricing</h5>
                <!-- Pricing -->
                <table width="50%" cellpadding="0" cellspacing="0" class="table table-bordered">
                    <thead>

                    </thead>
                    <tbody>
                        <tr class="table-primary">
                            <td >Member</td>
                            <td >Nonmember</td>
                        </tr>
                        <tr>
                            <td >Free</td>
                            <td >Free</td>
                        </tr>
                    </tbody>
                </table>
                <p>Sign in to access</p>


            </div>


            <div class="tab-pane fade" id="nav-credit" role="tabpanel" aria-labelledby="nav-credit-tab">
                <h5>Faculty relationship and financial disclosures</h5>
                <p>Dr. Cotter has reported no financial relationships with a commercial interest.</p>
                <p>Dr. Gilbert has disclosed the following financial relationships with a commercial interest:</p>
                <ul>
                    <li>Stock Shareholder: BiomeSense</li>
                    <li>Advisory Committee/Review Panel: DayTwo, Holobiome</li>
                </ul>
                <p>Dr. Loomba has disclosed the following financial relationships with a commercial interest:</p>
                <ul>
                    <li>Consultant or Advisory Board Member: Arrowhead Pharmaceuticals, AstraZeneca, Bird Rock Bio,
                        Boehringer Ingelheim, Bristol-Myer Squibb, Celgene, Cirius, CohBar, Conatus, Eli Lilly, Galmed,
                        Gemphire, Gilead, Glympse bio, GNI, GRI Bio, Intercept, Ionis, Janssen Inc., Merck, Metacrine,
                        Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Pfizer, Prometheus, Sanofi, Siemens,
                        Viking Therapeutics.</li>
                    <li>Grant/Research Support: Allergan, Boehringer-Ingelheim, Bristol-Myers Squibb, Cirius, Eli Lilly
                        and Company, Galectin Therapeutics, Galmed Pharmaceuticals, GE, Genfit, Gilead, Intercept,
                        Janssen, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, NuSirt, Pfizer, Prometheus,
                        Siemens.</li>
                    <li>Co-founder of Liponexus, Inc.</li>
                </ul>
                <p>Dr. Martens has disclosed the following financial relationships with a commercial interest:</p>
                <ul>
                    <li>Consultant: January Inc, Kaleido Biosciences</li>
                </ul>
                <p>Dr. Simren has disclosed the following financial relationships with a commercial interest:</p>
                <ul>
                    <li>Consultant or Advisory Board Member: AstraZeneca, Danone Nutricia Research, Nestlé, Almirall,
                        Allergan, Albireo, Glycom, Shire</li>
                    <li>Grant/Research Support: Danone Nutricia Research, Ferring Pharmaceuticals</li>
                    <li>Speaker: Tillotts, Menarini, Biocodex, Alfasigma, Takeda, Shire, Allergan, Almirall</li>
                </ul>
                <p>Dr. Thaiss has reported no financial relationships with a commercial interest.<br>
                    <br>Dr. Zhao has reported no financial relationships with a commercial interest.</p>

                <h5>Commercial supporters</h5>
                <p>Danone (GMFH Founding Supporter)</p>
                <p>Sanofi (Sustaining Supporter)</p>
                <p>Bio-K Plus International Inc.</p>
                <p>Rebiotix Inc, part of the Ferring Pharmaceuticals Group</p>
                <p>Seres Therapeutics<br><br></p>
            </div>
        </div>

        <div class="row">
            <div class="container">
                <hr>
                <h5 class="title-color">Sponsoring societies</h5>
                <p>American Gastroenterological Association (AGA) and European Society of Neurogastroenterology and
                    Motility (ESNM)</p>
                <h5 class="title-color">Endorsed by</h5>
                <p>American Neurogastroenterology and Motility Society (ANMS) and the European Society for Paediatric
                    Gastroenterology, Hepatology and Nutrition (ESPGHAN).</p>
                <p></p>
            </div>
        </div>
    </div>

    <!-- Right Side Card Content -->
    <div class="col-md-5">
        <!-- * Accomidations * -->
        <div class="container mt-3">
            <div class="row ">
                <div class="card text-light card-case" style="background-color:rgb(25, 36, 51); width: 20rem">
                    <img src="http://media.mycrowdwisdom.com.s3.amazonaws.com/aga/images/GMFH_REC_975_350.jpg"
                        class="card-img-top" alt="card header image">
                    <div class="card-body">
                        <p class="card-text pt-3">
                            <i class="fas fa-hourglass fa-2x text-warning"></i> Time to Complete: 3.5 hours
                        </p>

                        <p class=" card-text pt-3"><i class="fas fa-calendar-alt text-warning fa-2x" "=""></i>  Released: April 26, 2019</p>
                <p class=" card-text pt-3"><i class="fas fa-calendar-alt text-warning fa-2x" "=""></i>  Expires: March 1, 2021</p></div>
            </div>
          </div>
        </div>
      </div>
    </div>